Clinical Trial Update: Tuberculosis Clinical Trials Consortium Study 35 [Phase 1, Phase 2]

View source ↗

Summary

The Tuberculosis Clinical Trials Consortium Study 35, a Phase 1/Phase 2 trial sponsored by the CDC, has completed its investigation in latent tuberculosis infec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Latent Tuberculosis Infection

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Latent Tuberculosis | Phase 1, Phase 2 | Status: COMPLETED